Görlich-Gruppe
Investment opportunities in biotech for professional and semi-professional investors, focusing on capital market growth.
BioTech Fonds GmbH & Co. 1st BioTech KG targets professional and semi-professional investors, offering investment opportunities in the biotech sector. The company operates under the German Investment Code, requiring investors to commit a minimum of EUR 200,000 and possess the necessary expertise and knowledge for such investments. The fund is not available to citizens of the USA, Canada, Australia, Japan, Belarus, or Russia. BioTech Fonds generates revenue through capital market investments, leveraging the expertise of its management team, which includes Maximilian, the youngest son of Dr. Wolfgang. The company aims to modernize and rethink strategies within the biotech industry, providing a platform for investors seeking growth in this specialized market.
Keywords: biotech, investment, professional investors, capital market, Germany, fund, expertise, revenue, management, growth
